2024
DOI: 10.20944/preprints202404.0437.v1
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Drug Development for Alzheimer’s and Parkinson’s Disease: Where Do We Go Now?

Lisa Sequeira,
Sofia Benfeito,
Carlos Fernandes
et al.

Abstract: Neurodegenerative diseases (NDs) are a set of progressive, chronic, and incurable diseases characterized by the gradual loss of neurons, culminating in the decline of cognitive and/or motor functions. Alzheimer’s disease (AD) and Parkinson’s disease (PD) are the most common NDs and represent an enormous burden both in terms of human suffering and economic cost. The available therapies for AD and PD only provide symptomatic and palliative relief for a limited period and are unable to modify the diseases’ progre… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 223 publications
0
0
0
Order By: Relevance